Jay Pandit, MD
Jay Pandit, MD
  • Director of Digital Medicine, Assistant Professor of Cardiovascular Disease and Molecular Medicine, Scripps Research and Translational Institute.
  • Serves as Regional Director of the Bluhm Cardiovascular Institute’s Clinical Trials Unit.
  • Physician Entrepreneur with prior start up experience.
  • Attended Stanford University, Medical School and Internal Medicine training at the University of California San Francisco
  • Cardiovascular Diseases Fellowship Training at Northwestern University.
  • Awarded American Heart Association Innovation Award, has completed a Device Development Fellowship and the LEAD Certificate From the Stanford School of Business.
  • He has executed on multiple clinical trials and is well versed with taking an idea from zero to one and scaling to commercialization.
Peter U. Feig, MD
Peter U. Feig, MD
  • President of PF Pharmaceutical Development, LLC, providing consultant services to the Pharmaceutical, Device, and Biotechnology Industries and to Venture Capital firms.
  • Expertise in drug development, regulatory strategy, and translational science.
  • Formerly Senior Director, vice-president, and CMO in large and small pharmaceutical companies, including Merck Research Laboratories, Bayer Pharmaceuticals, Karos Pharmaceuticals.
  • Led large clinical programs for new antihypertensive and antidiabetic drugs development; mentored strong clinical teams; worked closely with basic science and commercial teams; headed company safety boards.
  • Developed multiple cardiovascular, metabolic, and other compounds and achieved regulatory approval worldwide of three new molecular entities.
  • Maintains an academic career as Clinical Associate Professor of Medicine at Weill Cornell Medical College where he is also a consultant to the Clinical Translational Science Center, developing courses in translational science and, until recently, attending physician at the Yale-affiliated VA Medical Center.